Vanda Pharmaceuticals, Inc. Reports First Quarter 2013 Results

Published: May 09, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WASHINGTON, May 9, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced financial and operational results for the first quarter ended March 31, 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news